SKZ CONSULTING LTD

Financial Health Score: C+ (Marginal with Qualifying Factors)

Explanation: The patient is suffering from a bout of acute short-term liquidity pressure, primarily presenting as a working capital deficit. However, the underlying business operations show signs of vitality. The company has successfully recovered from a severe chronic condition (negative equity in 2019/2020) to achieve positive net assets, but recent expansion efforts have strained its immediate cash reserves and current liabilities. The presence of a substantial director's loan artificially inflates the short-term debt profile, making the condition appear more critical than the operational reality.

1. Key Vital Signs

• Current Ratio (Liquidity Pulse): 0.83:1 Calculated as Current Assets (£26,942) divided by Current Liabilities (£32,432). A reading below 1 indicates that the company does not have enough short-term assets to cover its short-term debts. This is a symptom of financial hypertension—pressure is building on the company's immediate cash flow.
• Net Current Assets (Working Capital Blood Pressure): -£5,490 The company has a negative working capital position. In 2023, this was a healthy £1,480. The sudden drop is a symptom of an underlying shift in the business structure that requires immediate attention.
• Net Assets (Financial Constitution): £951 While positive, this is a significant drop from £5,097 in 2023. The business has a very thin equity cushion, leaving it highly vulnerable to unexpected financial shocks.
• Cash Reserves (Financial Hydration): £14,361 Cash levels have dipped slightly from £15,952 in 2023, but remain at reasonable levels compared to historical averages (e.g., £3,622 in 2019). The patient is not bleeding out, but cash flow needs monitoring.
• Debtors (Arterial Plaque): £12,581 Money owed to the company has jumped significantly from £9,379 to £12,581. This ties up vital cash that the business needs to operate.

2. Diagnosis

The Financial Data Reveals a Business Experiencing "Growing Pains" Funded by the Director

When examining the symptoms, the most glaring anomaly is the sudden spike in current liabilities, which jumped from £23,851 to £32,432. A closer look at the "blood work" (the balance sheet notes) reveals the primary cause: The Director's Loan Account has surged from £454 to £16,439.

Rather than a tumor of bad debt, this director loan is essentially a life-support system funded by the owner. Mr. Zafar has injected significant personal capital into the business over the last year. Where did this money go?

1. Capital Expenditure: The company invested £4,332 in new plant, machinery, and fixtures.
2. Staffing Expansion: The average employee count doubled from 2 to 4, which inherently increases the operational "burn rate" (evidenced by the new £4,157 net wages liability).

Simultaneously, the business has been paying down its external obligations—long-term bank loans decreased from £9,354 to £5,820, and trade creditors, VAT, and Corporation tax liabilities have all been reduced.

The diagnosis: The underlying operational trade health is actually improving, but the balance sheet is artificially stressed because the director is financing an expansion phase out of his own pocket, rather than through retained profits or external lending. The negative working capital is a real risk if the director were to suddenly demand repayment of that £16,439 loan, which could trigger a fatal cash flow crisis.

3. Prognosis

Guarded but Improving, Pending Cash Flow Management

The long-term prognosis is surprisingly optimistic if the immediate liquidity strain is managed. Looking at the patient's medical history, SKZ Consulting was in critical condition in 2019/2020 with negative net assets of over £18,000. By 2023, it had nursed itself back to a positive net asset position of £5,097.

The current dip to £951 in net assets is a relapse, but it is a calculated relapse driven by investment rather than operational failure. If the newly hired staff and newly acquired assets generate increased revenue in the 2025 financial year, the company will likely flush out the working capital deficit and return to a stable condition. However, if revenue does not scale to match the new overheads, the company will quickly burn through its cash reserves and may require further life support from the director.

4. Recommendations

To restore full financial wellness and reduce the current liquidity strain, the following "treatments" are prescribed:

• Accelerate Debtor Collection: With £12,581 sitting in trade and other debtors, the company must improve its credit control "circulation." Chasing outstanding invoices aggressively will convert these receivables into cash, directly improving the current ratio without requiring additional director loans.
• Formalize the Director's Loan: The £16,439 owed to Mr. Zafar is currently classified as a current liability (due within one year). This should be restructured into a long-term loan agreement. Moving this to "Creditors Due After More Than One Year" would instantly cure the negative working capital symptom, transforming the current ratio to a healthy 1.68:1 and providing a truer picture of operational liquidity.
• Monitor the Burn Rate: With staff numbers doubling, the monthly overhead has increased substantially. Implement a 13-week rolling cash flow forecast to ensure that the £14,361 cash balance provides sufficient runway, especially during seasonal dips in revenue common to the accounting and tax consultancy sector.
• Review Asset Utilization: The company has invested in new equipment and staff. Monitor the return on investment (ROI) of these assets closely over the next 6-12 months. If the increased capacity does not translate into increased turnover, the business may need to consider cost-reduction surgery to prevent further equity erosion.